Apotex Recalls Latanoprost Ophthalmic Solution Due to Sterility Concerns
Apotex Inc. is recalling Latanoprost Ophthalmic Solution, 0.005%, because it failed a preservative effectiveness test, raising concerns about potential microbial growth.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an ophthalmic product, which poses a significant risk of infection or injury.
Plain-English summary
Apotex Inc. is voluntarily recalling 50,982 bottles of Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL), 2.5 mL bottle, Rx only. The product is identified by Lot # JX1877 and has an expiration date of 06/13. The recall was initiated because the product failed the Preservative Effectiveness Test (PET) at expiry, which means the product may be susceptible to microbial growth before the stated expiration date.
The recalled product was distributed nationwide. It was manufactured by Apotex Inc. in Toronto, Ontario, Canada, and manufactured for Apotex Corp. in Weston, FL. The NDC is 60505-0565-1 and the UPC is 3 60505 05651 4.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on alternative treatments. The product should be returned to the pharmacy or point of purchase.
The recalled product
- Product
- Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL), 2.5 mL bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario Canada M9L 1T9; Manufactured for: Apotex Corp., Weston, FL 33326; NDC 60505-0565-1; UPC 3 60505 05651 4.
- Manufacturer
- Apotex Inc
- Category
- Drug — Ophthalmic Solution
- Affected units
- 50,982
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: JX1877
- Exp 06/13
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Apotex Inc
See all →- SevereApotex Recalls Metformin Hydrochloride Extended-Release Tablets Due to NDMA Impurity
FDA (Drugs) · 2020-06-24
- SevereApotex Recalls Equate Ranitidine Tablets Due to Possible NDMA Contamination
FDA (Drugs) · 2019-11-20
- SevereApotex Recalls Walgreens Wal-Zan 150 Tablets Due to NDMA Contamination Risk
FDA (Drugs) · 2019-11-20
- SevereApotex Recalls Equate Ranitidine Tablets Due to NDMA Contamination
FDA (Drugs) · 2019-11-20
- SevereRite Aid Ranitidine Tablets Recalled for Potential NDMA Contamination
FDA (Drugs) · 2019-11-20
Same hazard · microbial growth
See all →- ModerateSysco Classic and Bay Valley Foods Thank You Chocolate Pudding Recall
FDA (Food) · 2025-06-11
- ModerateRed Shell Teriyaki Sauce Recall Due to Microbial Growth
FDA (Food) · 2025-04-16
- ModerateOzona Organics and Go Healthy Liquid Probiotics recalled for potential microbial growth
FDA (Food) · 2023-10-04
- HighROi CPS LLC Recalls Regard Dressing Change Trays Due to Microbial Growth
FDA (Devices) · 2021-05-19
- SevereReese Hollandaise Sauce Recalled Due to Compromised Vacuum Seals
FDA (Food) · 2021-02-17